2026 Scientific Sessions

Workshop on the Treatment of Pulmonary Embolism: PERT Frameworks, Guideline Updates, and Procedural Skills (CME)

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.​

​Credit Designation
SCAI designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.​

​ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 3.75 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Introductory Remarks: Strengthening Your Pulmonary Embolism Response Team
Catalin Toma, M.D., University of Pittsburgh Medical Center, Pittsburgh, PA
Developing a Multidisciplinary PERT Program: Lessons Learned and Best Practices
Jun Li, M.D., FSCAI, University Hospitals Harrington Heart & Vascular Institute, Parma, OH
PERT Centers of Excellence
Kenneth Rosenfield, M.D., MHCDS, MSCAI, Mass General Brigham: Massachusetts General Hospital, Bedford, NH
Up-to-Date Landscape of PE Data
Jay S. Giri, MD, FSCAI, Hospital of the University of Pennsylvania, Philadelphia, PA
Panel Discussion
Wissam A Jaber, M.D., FSCAI, Emory University Hospital, Atlanta, GA and Andrew J. Klein, M.D., FSCAI, Piedmont Heart Institute, Atlanta, GA
Acute Pulmonary Embolism Guidelines 2026: Big Picture and Key Takeaways
Jay S. Giri, MD, FSCAI, Hospital of the University of Pennsylvania, Philadelphia, PA
Clarifying Disease Severity: The Acute PE Clinical Categorization Classification System
Michael N. Young, MD, FSCAI, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Discussion
Advanced Therapies in Acute Pulmonary Embolism: Matching Risk, Indication, and Evidence
Jun Li, M.D., FSCAI, University Hospitals Harrington Heart & Vascular Institute, Parma, OH
On the Horizon: Clinical Trials That May Impact Future Guidelines
Sanjum S Sethi, M.D., MPH, FSCAI, NewYork-Presbyterian Columbia University Irving Medical Center, New York, NY
Panel Discussion and Audience Q&A
Preprocedural Patient Evaluation-Risk Assessment
Sripal Bangalore, MD, MHA, FSCAI, NYU Grossman School of Medicine, New York, NY
Preprocedural Evaluation-Imaging and Device Selection
Vikas Aggarwal, M.B.B.S., FSCAI, Henry Ford Health System, Ann Arbor, MI
Procedural Workflow: How to Avoid Complications
Catalin Toma, M.D., University of Pittsburgh Medical Center, Pittsburgh, PA
When to ECMO
Vladimir Lakhter, DO, Temple University Hospital – Main Campus, Philadelphia, PA
Panel Discussion
AlphaVac Hands-on Station (Angiodynamics)
Sukhdeep Singh Basra, MD, MPH, McGovern Medical School, Houston, TX